Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.33 EUR | +0.75% |
|
+3.81% | +4.27% |
Apr. 25 | Transcript : Revenio Group Oyj, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Revenio Group Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analyst opinion has improved significantly over the past four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 36.13 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.27% | 810M | - | ||
-29.56% | 15.68B | A | ||
-58.81% | 2.03B | C+ | ||
+13.47% | 1.79B | - | ||
-21.75% | 1.3B | - | ||
+25.80% | 1.27B | B+ | ||
-37.72% | 715M | - | ||
-38.88% | 697M | - | C- | |
-30.29% | 584M | B+ | ||
-14.83% | 278M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- REG1V Stock
- Ratings Revenio Group Oyj